The sorbitol in prunes acts as a natural laxative
Increasing awareness of diabetes and obesity, coupled with rising disposable incomes and government initiatives to improve chronic disease management, are key factors driving the significant growth potential of the GLP-1 receptor agonist market in the Asia Pacific region
However, in a LIVE sub-study, myocardial glucose utilization did not improve in the liraglutide group as examined by F-fluorodeoxyglucose positron emission tomography [41], similar to a study using albiglutide [42]
A separate In a large cohort of patients with type 2 diabetes, researchers found that GLP-1 use was not associated with a higher incidence of NAION but was linked to another eye condition: diabetic retinopathy
specifically examined patients with MASLD cirrhosis and type 2 diabetes, finding that GLP-1 receptor agonist initiation was linked to reduced risk of unfavorable liver outcomes including hepatic decompensation events and mortality from any cause (aHR: 0.78, 95%CI: 0.68-0.90) relative to non-users, suggesting potential benefits even in advanced liver disease populations [58]